By: Joseph Titus Yekeryan
Liberia’s public health expert Dr. Mosoka P. Fallah is recommending that frontline Health Workers in the Country and people with higher risks conditions be the first to take the recently received Coronavirus vaccines.
Dr. Fallah speaking to a team of Journalists from the United States of America via telephone on Wednesday, said frontline health workers are the most vulnerable people to the coronavirus and as such, the need to prioritize them should not be overemphasized.
He said health workers need to protect themselves to protect others, adding that they will have the energy to protect people who are seeking medication when they first take precaution in fighting the pandemic.
Additionally, Dr. Fallah said people with higher risks of illnesses should also benefit from the vaccines on grounds that people with high-potency and diabetes are the ones also vulnerable because when they contract the virus; it has a rapid progression to a serious condition that leads to death.
“We will need to prioritize our Frontline health workers and people with major illnesses that are making them vulnerable to the virus because when we engage the fight from that standpoint, it will be fine for us as a country,” Dr. Fallah said.
Also speaking on fear of the vaccines, Dr. Fallah said the issue of vaccines fear and hesitancy is normal around the world and believes that there should not be fear.“
Normally people can be afraid when they talk about vaccines but I don’t think that people should be in fear because the World Health Organization is the one responsible to prequalify all vaccines and that it is the same organization that has qualified the coronavirus vaccines.
“WHO is the one qualifying all the other vaccines that we’ve been taking and giving to our children so why are people not in fear about the others but only the Coronavirus vaccines? So in my mind, I don’t think we should be in fear.”
He described the vaccine as an important moment for Liberia as it gives the people a tool to halt a global disease that has already impacted the lives and livelihoods of so many.
On March 5, 2021, Liberia received 96,000 vaccine doses shipped via the COVAX initiative, a partnership between CEPI, Gavi, UNICEF and WHO.
The arrival of the vaccines in Liberia is part of the historic step towards achieving the goal of equitable distribution of Covid-19 vaccines globally, in what will be the largest vaccine procurement and supply operation in history.
Manufactured by the Serum Institute of India, the arrival of the 96,000 doses of the AstraZeneca vaccine marks the first batch of vaccine shipped to Liberia amid its unprecedented efforts to help fight the pandemic